Date of inclusion: 16 April 2021
Share price on inclusion in Marc & Stuart's Top Picks: $2.55
52-week range: A$1.16 / A$3.45
Risk Level: High
The gold standard in diagnostic functional lung imaging technology
Cyclopharm is a supplier of radiopharmaceuticals, that is, radioisotopes used in medical diagnosis. Its core product is Technegas, which is an ultra-fine dispersion of Technetium-labelled carbon. Technegas is inhaled by a patient to allow easy diagnosis of pulmon...